Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2002 Dec;73(6):636–642. doi: 10.1136/jnnp.73.6.636

Apathy in Parkinson's disease

G Pluck 1, R Brown 1
PMCID: PMC1757348  PMID: 12438462

Abstract

Objective: To assess apathy in patients with Parkinson's disease and its relation to disability, mood, personality, and cognition.

Methods: Levels of apathy in 45 patients with Parkinson's disease were compared with a group of 17 similarly disabled patients with osteoarthritis. Additional neuropsychiatric data were collected concerning levels of depression, anxiety, and hedonic tone. Personality was assessed with the tridimensional personality questionnaire. Cognitive testing included the mini-mental state examination, the Cambridge examination of cognition in the elderly, and specific tests of executive functioning.

Results: Patients with Parkinson's disease had significantly higher levels of apathy than equally disabled osteoarthritic patients. Furthermore, within the Parkinson sample, levels of apathy appear to be unrelated to disease progression. The patients with Parkinson's disease with the highest levels of apathy where not more likely to be depressed or anxious than those with the lowest levels of apathy, though they did show reduced hedonic tone. No differences in personality traits were detected in comparisons between patients with Parkinson's disease and osteoarthritis, or between patients in the Parkinson group with high or low levels of apathy. As a group, the patients with Parkinson's disease tended not to differ significantly from the osteoarthritic group in terms of cognitive skills. However, within the Parkinson's disease sample, the high apathy patients performed significantly below the level of the low apathy patients. This was particularly evident on tests of executive functioning.

Conclusions: Apathy in Parkinson's disease is more likely to be a direct consequence of disease related physiological changes than a psychological reaction or adaptation to disability. Apathy in Parkinson's disease can be distinguished from other psychiatric symptoms and personality features that are associated with the disease, and it is closely associated with cognitive impairment. These findings point to a possible role of cognitive mechanisms in the expression of apathy.

Full Text

The Full Text of this article is available as a PDF (182.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarsland D., Cummings J. L., Larsen J. P. Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 2001 Feb;16(2):184–191. doi: 10.1002/1099-1166(200102)16:2<184::aid-gps304>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  2. Aarsland D., Larsen J. P., Lim N. G., Janvin C., Karlsen K., Tandberg E., Cummings J. L. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):492–496. doi: 10.1136/jnnp.67.4.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aarsland D., Litvan I., Larsen J. P. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2001 Winter;13(1):42–49. doi: 10.1176/jnp.13.1.42. [DOI] [PubMed] [Google Scholar]
  4. BECK A. T., WARD C. H., MENDELSON M., MOCK J., ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561–571. doi: 10.1001/archpsyc.1961.01710120031004. [DOI] [PubMed] [Google Scholar]
  5. Braak H., Braak E., Yilmazer D., Schultz C., de Vos R. A., Jansen E. N. Nigral and extranigral pathology in Parkinson's disease. J Neural Transm Suppl. 1995;46:15–31. [PubMed] [Google Scholar]
  6. Brown R. G., MacCarthy B., Gotham A. M., Der G. J., Marsden C. D. Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol Med. 1988 Feb;18(1):49–55. doi: 10.1017/s0033291700001872. [DOI] [PubMed] [Google Scholar]
  7. Brown R. G., Marsden C. D. Cognitive function in Parkinson's disease: from description to theory. Trends Neurosci. 1990 Jan;13(1):21–29. doi: 10.1016/0166-2236(90)90058-i. [DOI] [PubMed] [Google Scholar]
  8. Brown R. G., Pluck G. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. Trends Neurosci. 2000 Sep;23(9):412–417. doi: 10.1016/s0166-2236(00)01626-x. [DOI] [PubMed] [Google Scholar]
  9. Castellon S. A., Hinkin C. H., Wood S., Yarema K. T. Apathy, depression, and cognitive performance in HIV-1 infection. J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):320–329. doi: 10.1176/jnp.10.3.320. [DOI] [PubMed] [Google Scholar]
  10. Cloninger C. R. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987 Jun;44(6):573–588. doi: 10.1001/archpsyc.1987.01800180093014. [DOI] [PubMed] [Google Scholar]
  11. Cloninger C. R., Svrakic D. M., Przybeck T. R. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993 Dec;50(12):975–990. doi: 10.1001/archpsyc.1993.01820240059008. [DOI] [PubMed] [Google Scholar]
  12. Cole S. A., Woodard J. L., Juncos J. L., Kogos J. L., Youngstrom E. A., Watts R. L. Depression and disability in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):20–25. doi: 10.1176/jnp.8.1.20. [DOI] [PubMed] [Google Scholar]
  13. Cummings J. L. Cholinesterase inhibitors: A new class of psychotropic compounds. Am J Psychiatry. 2000 Jan;157(1):4–15. doi: 10.1176/ajp.157.1.4. [DOI] [PubMed] [Google Scholar]
  14. Cummings J. L., Darkins A., Mendez M., Hill M. A., Benson D. F. Alzheimer's disease and Parkinson's disease: comparison of speech and language alterations. Neurology. 1988 May;38(5):680–684. doi: 10.1212/wnl.38.5.680. [DOI] [PubMed] [Google Scholar]
  15. Cummings J. L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D. A., Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994 Dec;44(12):2308–2314. doi: 10.1212/wnl.44.12.2308. [DOI] [PubMed] [Google Scholar]
  16. Fibiger H. C. The neurobiological substrates of depression in Parkinson's disease: a hypothesis. Can J Neurol Sci. 1984 Feb;11(1 Suppl):105–107. doi: 10.1017/s0317167100046230. [DOI] [PubMed] [Google Scholar]
  17. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  18. Gotham A. M., Brown R. G., Marsden C. D. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry. 1986 Apr;49(4):381–389. doi: 10.1136/jnnp.49.4.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Guttman M., Jaskolka J. The use of pramipexole in Parkinson's disease: are its actions D(3) mediated? Parkinsonism Relat Disord. 2001 Jul;7(3):231–234. doi: 10.1016/s1353-8020(00)00062-6. [DOI] [PubMed] [Google Scholar]
  20. Hobson P., Meara J. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test. Age Ageing. 1999 Jan;28(1):39–43. doi: 10.1093/ageing/28.1.39. [DOI] [PubMed] [Google Scholar]
  21. Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427–442. doi: 10.1212/wnl.17.5.427. [DOI] [PubMed] [Google Scholar]
  22. Hutchinson M., Fazzini E. Cholinesterase inhibition in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):324–325. doi: 10.1136/jnnp.61.3.324-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Isella Valeria, Melzi Paola, Grimaldi Marco, Iurlaro Simona, Piolti Roberto, Ferrarese Carlo, Frattola Lodovico, Appollonio Ildebrando. Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Mov Disord. 2002 Mar;17(2):366–371. doi: 10.1002/mds.10041. [DOI] [PubMed] [Google Scholar]
  24. Joyce J. N., Ryoo H., Gurevich E. V., Adler C., Beach T. Ventral striatal D(3) receptors and Parkinson's Disease. Parkinsonism Relat Disord. 2001 Jul;7(3):225–230. doi: 10.1016/s1353-8020(00)00060-2. [DOI] [PubMed] [Google Scholar]
  25. Krupp B. H. Ethical considerations in apathy syndromes. Psychiatr Ann. 1997 Jan;27(1):50–54. doi: 10.3928/0048-5713-19970101-12. [DOI] [PubMed] [Google Scholar]
  26. Kuzis G., Sabe L., Tiberti C., Dorrego F., Starkstein S. E. Neuropsychological correlates of apathy and depression in patients with dementia. Neurology. 1999 Apr 22;52(7):1403–1407. doi: 10.1212/wnl.52.7.1403. [DOI] [PubMed] [Google Scholar]
  27. Le Bras C., Pillon B., Damier P., Dubois B. At which steps of spatial working memory processing do striatofrontal circuits intervene in humans? Neuropsychologia. 1999 Jan;37(1):83–90. doi: 10.1016/s0028-3932(98)00041-4. [DOI] [PubMed] [Google Scholar]
  28. Leentjens A. F., Verhey F. R., Luijckx G. J., Troost J. The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord. 2000 Nov;15(6):1221–1224. doi: 10.1002/1531-8257(200011)15:6<1221::aid-mds1024>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  29. Levy M. L., Cummings J. L., Fairbanks L. A., Masterman D., Miller B. L., Craig A. H., Paulsen J. S., Litvan I. Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):314–319. doi: 10.1176/jnp.10.3.314. [DOI] [PubMed] [Google Scholar]
  30. Lieberman A., Ranhosky A., Korts D. Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study. Neurology. 1997 Jul;49(1):162–168. doi: 10.1212/wnl.49.1.162. [DOI] [PubMed] [Google Scholar]
  31. Litvan I., Mega M. S., Cummings J. L., Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology. 1996 Nov;47(5):1184–1189. doi: 10.1212/wnl.47.5.1184. [DOI] [PubMed] [Google Scholar]
  32. Marin R. S., Biedrzycki R. C., Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991 Aug;38(2):143–162. doi: 10.1016/0165-1781(91)90040-v. [DOI] [PubMed] [Google Scholar]
  33. Marsh N. V., Kersel D. A., Havill J. H., Sleigh J. W. Caregiver burden at 1 year following severe traumatic brain injury. Brain Inj. 1998 Dec;12(12):1045–1059. doi: 10.1080/026990598121954. [DOI] [PubMed] [Google Scholar]
  34. Mega M. S., Cummings J. L. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci. 1994 Fall;6(4):358–370. doi: 10.1176/jnp.6.4.358. [DOI] [PubMed] [Google Scholar]
  35. Menza M. A., Golbe L. I., Cody R. A., Forman N. E. Dopamine-related personality traits in Parkinson's disease. Neurology. 1993 Mar;43(3 Pt 1):505–508. doi: 10.1212/wnl.43.3_part_1.505. [DOI] [PubMed] [Google Scholar]
  36. Menza M. A., Mark M. H., Burn D. J., Brooks D. J. Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1995 Spring;7(2):176–179. doi: 10.1176/jnp.7.2.176. [DOI] [PubMed] [Google Scholar]
  37. Nelson H. E. A modified card sorting test sensitive to frontal lobe defects. Cortex. 1976 Dec;12(4):313–324. doi: 10.1016/s0010-9452(76)80035-4. [DOI] [PubMed] [Google Scholar]
  38. Owen A. M., Evans A. C., Petrides M. Evidence for a two-stage model of spatial working memory processing within the lateral frontal cortex: a positron emission tomography study. Cereb Cortex. 1996 Jan-Feb;6(1):31–38. doi: 10.1093/cercor/6.1.31. [DOI] [PubMed] [Google Scholar]
  39. Poewe W., Gerstenbrand F., Ransmayr G., Plörer S. Premorbid personality of Parkinson patients. J Neural Transm Suppl. 1983;19:215–224. [PubMed] [Google Scholar]
  40. Rabkin J. G., Ferrando S. J., van Gorp W., Rieppi R., McElhiney M., Sewell M. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. J Neuropsychiatry Clin Neurosci. 2000 Fall;12(4):451–457. doi: 10.1176/jnp.12.4.451. [DOI] [PubMed] [Google Scholar]
  41. Resnick B., Zimmerman S. I., Magaziner J., Adelman A. Use of the Apathy Evaluation Scale as a measure of motivation in elderly people. Rehabil Nurs. 1998 May-Jun;23(3):141–147. doi: 10.1002/j.2048-7940.1998.tb01766.x. [DOI] [PubMed] [Google Scholar]
  42. Ringman John M., Diaz-Olavarrieta Claudia, Rodriguez Yaneth, Fairbanks Lynn, Cummings Jeffrey L. The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson's disease in Mexico. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Jun;15(2):99–105. [PubMed] [Google Scholar]
  43. Rodnitzky R. L. Visual dysfunction in Parkinson's disease. Clin Neurosci. 1998;5(2):102–106. [PubMed] [Google Scholar]
  44. Siemers E. R., Shekhar A., Quaid K., Dickson H. Anxiety and motor performance in Parkinson's disease. Mov Disord. 1993 Oct;8(4):501–506. doi: 10.1002/mds.870080415. [DOI] [PubMed] [Google Scholar]
  45. Singer E. Social costs of Parkinson's disease. J Chronic Dis. 1973 Apr;26(4):243–254. doi: 10.1016/0021-9681(73)90105-7. [DOI] [PubMed] [Google Scholar]
  46. Snaith P. Anhedonia: a neglected symptom of psychopathology. Psychol Med. 1993 Nov;23(4):957–966. doi: 10.1017/s0033291700026428. [DOI] [PubMed] [Google Scholar]
  47. Snaith R. P., Hamilton M., Morley S., Humayan A., Hargreaves D., Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995 Jul;167(1):99–103. doi: 10.1192/bjp.167.1.99. [DOI] [PubMed] [Google Scholar]
  48. Starkstein S. E., Mayberg H. S., Preziosi T. J., Andrezejewski P., Leiguarda R., Robinson R. G. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1992 Spring;4(2):134–139. doi: 10.1176/jnp.4.2.134. [DOI] [PubMed] [Google Scholar]
  49. Starkstein S. E., Petracca G., Chemerinski E., Tesón A., Sabe L., Merello M., Leiguarda R. Depression in classic versus akinetic-rigid Parkinson's disease. Mov Disord. 1998 Jan;13(1):29–33. doi: 10.1002/mds.870130109. [DOI] [PubMed] [Google Scholar]
  50. Thomas P., Clément J. P., Hazif-Thomas C., Léger J. M. Family, Alzheimer's disease and negative symptoms. Int J Geriatr Psychiatry. 2001 Feb;16(2):192–202. doi: 10.1002/1099-1166(200102)16:2<192::aid-gps301>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  51. Wenzel A., Holt C. S. Dot probe performance in two specific phobias. Br J Clin Psychol. 1999 Nov;38(Pt 4):407–410. doi: 10.1348/014466599163006. [DOI] [PubMed] [Google Scholar]
  52. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES